@article{91d9fb54577a4c4c8f5b8bc00aa40ea3,
title = "Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease",
author = "McCullough, \{Peter A.\} and Sandberg, \{Keisha R.\} and Steven Borzak and Hudson, \{Michael P.\} and Mukesh Garg and Manley, \{Harold J.\}",
note = "1 Department of Basic Science, Cardiology Section, University of Missouri-Kansas City, School of Medicine, Truman Medical Center, Kansas City, Mo 64108, USA.
[email protected] Background: There have been no randomized trials of cardioprotective therapy after acute myocardial infarction in patients with chronic kidney disease who should be largely eligible for aspirin (acetylsalicylic acid; ASA) and beta-blockers (BB) as a base of therapy.",
year = "2002",
month = aug,
day = "1",
doi = "10.1067/MHJ.2002.125513",
language = "American English",
volume = "144",
journal = "American Heart Journal",
issn = "1097-6744",
number = "2",
}